Explicit and implicit copayments for phototherapy
Type:Uv phototherapy Time:2014-11-17 14:59:35Explicit and implicit copayments for phototherapy: examining the cost of commuting.
Yentzer BA1, Gustafson CJ, Feldman SR.
Author information
Abstract
BACKGROUND:
Whereas phototherapy is a safe and cost-effective treatment modality for psoriasis, economic disincentives discourage its
use, including both direct and indirect costs to the patient.
PURPOSE:
To determine when it may be cost-effective for patients to purchase a home light unit versus driving to clinic for outpatient
phototherapy sessions.
METHODS:
Estimates of expenses associated with 3 months of outpatient phototherapy were determined and compared to the price of a home
phototherapy unit. Factors examined included the cost of gasoline (based on the national average), fuel efficiency of the
vehicle, cost of owning and operating a motor vehicle, lost wages, and copayments.
RESULTS:
The cost for a standard 6-bulb narrowband UVB home unit is approximately $2600. Direct and indirect expenses imposed on
patients increase with distance travelled to the dermatologist. If a patient lives 20 or more miles away from the
dermatologist, the expenses associated with travel can total more than the out of pocket expense of purchasing a home
phototherapy unit.
LIMITATIONS:
This small analysis only accounted for the first 3 months of treatment and likely underestimates the total costs that
patients would experience over a lifetime of treatment.
CONCLUSIONS:
It may be beneficial for physicians to educate patients on the cost-burden of in-office versus home phototherapy because
patients can use these parameters to determine which option would be more cost-effective for them.
www.kerneluvb.com----The leader manufacturer of UV Phototherapy.